The CE marking clears the way for the company to market its PET system across the EU after launching in the US market in July ...

GE HealthCare has secured the FDA’s approval for an injectable, radioactive imaging agent that gives clinicians a clearer ...

Positrigo, a Swiss based company developing nuclear medical imaging devices to advance functional brain imaging, has achieved ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

Positron emission tomography (PET) beta-amyloid imaging is a vital tool in the diagnosis and treatment of Alzheimer’s disease. Fortunately, the Centers for Medicare and Medicaid Services (CMS ...

New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported in July. But ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

Alzheimer's disease is a brain disorder that destroys memory and thinking skills. Early symptoms include difficulty ...

A diagnosis in the early stages may allow you to start treatments that can slow disease progression.

GE HealthCare plans for brain-imaging boom in wake of Alzheimer's drug gains “As amyloid-targeting therapies continue to show meaningful results against Alzheimer's disease, PET imaging can help ...

Hot Spot. GWAS of tau PET scans found a single locus where SNPs (circles) were associated with higher tangle loads. The strongest signal came from SNP rs2113389 (gray diamond). [Courtesy of Nho et al.

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...